glp-1 and bipolar The receptor agonist liraglutide reverses mania-like alterations memory deficits induced by D-amphetamine and augments lithium effects in mice: Relevance for disorder GLP-1 and the Degenerating Brain:

A double-blinded placebo-controlled phase 2 clinical study in obese patients weekly injections of mazdutide (9 mg) could cause 15.4% decreases in body weight over placebo after 24 weeks

This suggests that GLP-1 drugs could potentially reduce alcohol cravings in humans, providing a new treatment option for those struggling with alcohol addiction

GLP-1-Based Therapies: Mechanisms of Action, Development, and Clinical Impact HMX Understand the science behind GLP-1-based therapies and how theyre revolutionizing patient care

The initial Context of Use was narrow: improve glycaemic control in type 2 diabetes through incretin-mediated pancreatic beta-cell stimulation

California can and should lead on this issue

Its something youll want to discuss with your doctor